相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Models of psychedelic drug action: modulation of cortical-subcortical circuits
Manoj K. Doss et al.
BRAIN (2022)
Psychedelics
Benjamin Kelmendi et al.
CURRENT BIOLOGY (2022)
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
Arman A. Sadybekov et al.
NATURE (2022)
Structure-based discovery of nonhallucinogenic psychedelic analogs
Dongmei Cao et al.
SCIENCE (2022)
Selective serotonin 5-HT2A receptor antagonists
Austen B. Casey et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
Drummond E-Wen McCulloch et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Increased global integration in the brain after psilocybin therapy for depression
Richard E. Daws et al.
NATURE MEDICINE (2022)
The promises and perils of psychedelic pharmacology for psychiatry
Tristan D. McClure-Begley et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans
Dea Siggaard Stenbaek et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
Nakul Ravi Raval et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A non-hallucinogenic psychedelic analogue with therapeutic potential
Lindsay P. Cameron et al.
NATURE (2021)
The History of Psychedelics in Psychiatry
David E. Nichols et al.
PHARMACOPSYCHIATRY (2021)
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia et al.
TRENDS IN NEUROSCIENCES (2021)
Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Youwen Zhuang et al.
CELL (2021)
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
Mario de la Fuente Revenga et al.
CELL REPORTS (2021)
Psychedelic-inspired drug discovery using an engineered biosensor
Chunyang Dong et al.
CELL (2021)
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
Manoj K. Doss et al.
TRANSLATIONAL PSYCHIATRY (2021)
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas et al.
FRONTIERS IN PSYCHIATRY (2021)
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell et al.
NATURE MEDICINE (2021)
Trial of Psilocybin versus Escitalopram for Depression
Robin Carhart-Harris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
Natalie Hesselgrave et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience
Martin K. Madsen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
Ramona M. Rodriguiz et al.
SCIENTIFIC REPORTS (2021)
LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions
Carli Domenico et al.
CELL REPORTS (2021)
Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD
Joshua B. Burt et al.
ELIFE (2021)
Investigation of the Structure-Activity Relationships of Psilocybin Analogues
Adam K. Klein et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth
Calvin Ly et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects
David E. Olson
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects
David B. Yaden et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity
Katrin H. Preller et al.
BIOLOGICAL PSYCHIATRY (2020)
Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies
Lee E. Dunlap et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines
Farhan Ali et al.
NATURE COMMUNICATIONS (2020)
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Frederick S. Barrett et al.
SCIENTIFIC REPORTS (2020)
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Morten L. Kringelbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett et al.
NEUROIMAGE (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives
N. Milne et al.
METABOLIC ENGINEERING (2020)
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim et al.
CELL (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Serotonin in the gut: Blessing or a curse
Suhrid Banskota et al.
BIOCHIMIE (2019)
Ultra-large library docking for discovering new chemotypes
Jiankun Lyu et al.
NATURE (2019)
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal et al.
NEURON (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Hallucinations and Strong Priors
Philip R. Corlett et al.
TRENDS IN COGNITIVE SCIENCES (2019)
A Hallucinogenic Serotonin-2A Receptor Agonist Reduces Visual Response Gain and Alters Temporal Dynamics in Mouse V1
Angie M. Michaiel et al.
CELL REPORTS (2019)
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
R. L. Carhart-Harris et al.
PHARMACOLOGICAL REVIEWS (2019)
Molecular and anatomical organization of the dorsal raphe nucleus
Kee Wui Huang et al.
ELIFE (2019)
Neural correlates of the DMT experience assessed with multivariate EEG
Christopher Timmermann et al.
SCIENTIFIC REPORTS (2019)
Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (FLY) and benzodifuran (DragonFLY) analogs
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2019)
In vivo production of psilocybin in E. coli
Alexandra M. Adams et al.
METABOLIC ENGINEERING (2019)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Altered network hub connectivity after acute LSD administration
Felix Mueller et al.
NEUROIMAGE-CLINICAL (2018)
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD
Gustavo Deco et al.
CURRENT BIOLOGY (2018)
Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor
Katrin H. Preller et al.
ELIFE (2018)
A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
Vincent Beliveau et al.
JOURNAL OF NEUROSCIENCE (2017)
Long-term follow-up of psilocybin-facilitated smoking cessation
Matthew W. Johnson et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow
Candace R. Lewis et al.
NEUROIMAGE (2017)
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
Jose M. Palacios et al.
PSYCHOPHARMACOLOGY (2017)
Pavlovian conditioning-induced hallucinations result from overweighting of perceptual priors
A. R. Powers et al.
SCIENCE (2017)
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
Michael M. Schartner et al.
SCIENTIFIC REPORTS (2017)
Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations
F. Mueller et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)
Simon D. Brandt et al.
DRUG TESTING AND ANALYSIS (2016)
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
Thomas Pokorny et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
LSD Alters Eyes-Closed Functional Connectivity within the Early Visual Cortex in a Retinotopic Fashion
Leor Roseman et al.
HUMAN BRAIN MAPPING (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
David A. Martin et al.
EBIOMEDICINE (2016)
Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong et al.
ENEURO (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker et al.
SCIENCE (2013)
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model
Clint E. Canal et al.
DRUG TESTING AND ANALYSIS (2012)
Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs
Jesse Wood et al.
JOURNAL OF NEUROSCIENCE (2012)
An anatomically comprehensive atlas of the adult human brain transcriptome
Michael J. Hawrylycz et al.
NATURE (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Selective serotonergic excitation of callosal projection neurons
Daniel Avesar et al.
FRONTIERS IN NEURAL CIRCUITS (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro
Hiroyuki Yoshida et al.
NEUROSCIENCE RESEARCH (2011)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
γ-Secretase Inhibition Reduces Spine Density In Vivo via an Amyloid Precursor Protein-Dependent Pathway
Tobias Bittner et al.
JOURNAL OF NEUROSCIENCE (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
Danuta Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2009)
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Cullen L. Schmid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease
Steven Droogmans et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane
Efrain E. Garcia et al.
NEUROPHARMACOLOGY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
1-aminomethylbenzocycloalkanes:: Conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists
Thomas H. McLean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
SAR of psilocybin analogs:: Discovery of a selective 5-HT2C agonist
H Sard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Distinct temporal phases in the behavioral pharmacology of LSD:: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
D Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2005)
Gramine:: A vasorelaxing alkaloid acting on 5-HT2A receptors
G Froldi et al.
PLANTA MEDICA (2004)
Structural plasticity associated with exposure to drugs of abuse
TE Robinson et al.
NEUROPHARMACOLOGY (2004)
LSD, 5-HT (serotonin), and the evolution of a behavioral assay
JB Appel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Expression of Serotonin1A and Serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex
N Santana et al.
CEREBRAL CORTEX (2004)
A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation:: the involvement of MAP kinases
DM Kurrasch-Orbaugh et al.
JOURNAL OF NEUROCHEMISTRY (2003)
3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
V Setola et al.
MOLECULAR PHARMACOLOGY (2003)
The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT2A receptor induces agonist-independent internalization
JA Gray et al.
MOLECULAR PHARMACOLOGY (2003)
Molecular basis of partial agonism: Orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy
BJ Ebersole et al.
MOLECULAR PHARMACOLOGY (2003)
Ultrastructural localization of serotonin(2A) receptors in the middle layers of the rat prelimbic prefrontal cortex
LAH Miner et al.
NEUROSCIENCE (2003)
A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain
CD Nichols et al.
NEUROPSYCHOPHARMACOLOGY (2002)
A systems model of altered consciousness: Integrating natural and drug-induced psychoses
FX Vollenweider et al.
BRAIN RESEARCH BULLETIN (2001)